These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28746471)

  • 1. Impact of extracellular alkalinization on the survival of human CD24-/CD44+ breast cancer stem cells associated with cellular metabolic shifts.
    Wanandi SI; Yustisia I; Neolaka GMG; Jusman SWA
    Braz J Med Biol Res; 2017 Jul; 50(8):e6538. PubMed ID: 28746471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of breast cancer resistance protein and p-glycoprotein in residual breast cancer tissue after chemotherapy and its correlation with cancer stem cells].
    Qu HB; Fan YM; Han ML; Luo HJ; Xie J; Liu H; Liu H; Wu CY; Tang WX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):171-6. PubMed ID: 23643006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3 as a promising chemoresistance biomarker associated with the CD44
    Moreira MP; da Conceição Braga L; Cassali GD; Silva LM
    Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
    Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
    Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype.
    Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Martin-Castillo B; Vellon L; Menendez JA
    Cell Cycle; 2011 Nov; 10(22):3871-85. PubMed ID: 22127234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pilot study on the correlation between high incidence of CD44+/CD24 -/low/ABCG2- cells and poor prognosis in breast cancer].
    Gong JF; Yuan YH; Song GH; Yu J; Han Y; Jia J; Ren J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):465-70. PubMed ID: 18931706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the correlation factors on CD44+ CD24-/low ESA+ Lin- cell ratio in breast cancer].
    Wang R; Yang XQ; Lü Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jan; 45(1):53-6. PubMed ID: 24527582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of Rotenone-Treated Human Breast Cancer Stem Cell Survival Using Survivin Inhibitor YM155 is Associated to Oxidative Stress Modulation.
    Syahrani RA; Yunita E; Wanandi SI
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2631-2637. PubMed ID: 32986362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of CD24 and CD44 in breast cancer: a meta-analysis.
    Wang Z; Wang Q; Wang Q; Wang Y; Chen J
    Int J Biol Markers; 2017 Mar; 32(1):e75-e82. PubMed ID: 27470135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer.
    Tian J; Hachim MY; Hachim IY; Dai M; Lo C; Raffa FA; Ali S; Lebrun JJ
    Sci Rep; 2017 Jan; 7():40258. PubMed ID: 28054666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
    Calaf GM; Ponce-Cusi R; Abarca-Quinones J
    Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy.
    Kwak JH; Lee NH; Lee HY; Hong IS; Nam JS
    Oncotarget; 2016 Jul; 7(28):43518-43533. PubMed ID: 27270657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumour effects of a dual cancer-specific oncolytic adenovirus on Breast Cancer Stem cells.
    Li W; Li Y; Cui Y; Li S; Zhu Y; Shang C; Song G; Liu Z; Xiu Z; Cong J; Li T; Li X; Sun L; Jin N
    J Cell Mol Med; 2021 Jan; 25(2):666-676. PubMed ID: 33305893
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Putra A; Riwanto I; Putra ST; Wijaya I
    J Cancer Res Ther; 2020; 16(6):1302-1308. PubMed ID: 33342788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells.
    Gupta V; Bhinge KN; Hosain SB; Xiong K; Gu X; Shi R; Ho MY; Khoo KH; Li SC; Li YT; Ambudkar SV; Jazwinski SM; Liu YY
    J Biol Chem; 2012 Oct; 287(44):37195-205. PubMed ID: 22936806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. POMC maintains tumor-initiating properties of tumor tissue-derived long-term-cultured breast cancer stem cells.
    Lin X; Chen W; Wei F; Zhou BP; Hung MC; Xie X
    Int J Cancer; 2017 Jun; 140(11):2517-2525. PubMed ID: 28214331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing CD44+/CD24(-) tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis.
    Wang KH; Kao AP; Chang CC; Lee JN; Hou MF; Long CY; Chen HS; Tsai EM
    Mol Cancer; 2010 Nov; 9():288. PubMed ID: 21044318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.
    Liu S; Cong Y; Wang D; Sun Y; Deng L; Liu Y; Martin-Trevino R; Shang L; McDermott SP; Landis MD; Hong S; Adams A; D'Angelo R; Ginestier C; Charafe-Jauffret E; Clouthier SG; Birnbaum D; Wong ST; Zhan M; Chang JC; Wicha MS
    Stem Cell Reports; 2014 Jan; 2(1):78-91. PubMed ID: 24511467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer.
    Hu C; Xu L; Liang S; Zhang Z; Zhang Y; Zhang F
    J Drug Target; 2016; 24(5):422-32. PubMed ID: 26339994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.